Skip to main content

Collision of SUD and COVID-19: A NIDA Update

Collision of SUD and COVID-19: A NIDA Update
A Recorded Webinar
Recorded on Wednesday, December 18, 2020

Jump to Course Contents
Description
The U.S. is now facing two intersecting health crises, the ongoing opioid overdose epidemic and the COVID-19 pandemic. Fortunately, we now live in a world where science can be quickly mobilized to find solutions to mitigate the worst effects. NIDA has swiftly responded to the COVID-19 crisis by supporting research in areas of basic science, prevention, treatment, epidemiology, and implementation, particularly at the intersection with substance use disorders. This presentation will provide an update on NIDA science underway to address the opioid crisis during the COVID pandemic and the implications for practice and policy.
Learning Objectives
  • Participants will examine the impact of the COVID pandemic on preventing and treating substance use disorders.
  • Participants will learn about research underway by NIDA to lessen the impact of these colliding public health problems.
  • Participants will acquire an understanding of how science can inform policy and practice related to addressing substance use disorder.

Presenter
Jack B. Stein, MSW, PhD

Jack B. Stein, MSW, PhD, joined NIDA in August 2012 as the Director of the Office of Science Policy and Communications (OSPC). He has over two decades of professional experience in leading national drug and HIV-related research, practice, and policy initiatives for NIDA, the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Office of National Drug Control Policy (ONDCP) where, before coming back to NIDA, he served as the Chief of the Prevention Branch. In March 2019, Stein was appointed NIDA Chief of Staff.

Guest Panelists
Jessica Hulsey, BA

Founder of the Addiction Policy Forum
Philip Rutherford, BA

Chief Operating Officer at Faces & Voices of Recovery
Redonna Chandler, PhD

Director of the AIDS Research Program and the HEALing Communities Study at the National Institute on Drug Abuse (NIDA)
Kurt Rasmussen, PhD

Director of the Division of Therapeutics and Medical Consequences (DTMC) at the National Institute on Drug Abuse (NIDA)
Will M. Aklin, PhD

Director of the Behavioral Therapy Development Program at the National institute on Drug Abuse (NIDA)
Jennifer A. Hobin, PhD

Deputy Director and Legislative Advisor in the Office of Science Policy and Communications at the National Institute on Drug Abuse (NIDA)

Interactivity
Polls and Q&A.

Price
Education is FREE to all professionals.
Earn 2 Continuing Education Hours (CEs)
To earn a CE Certificate for viewing this webinar, you must view the webinar in its entirety, pass the CE quiz, and complete the online survey evaluation.

  1. Upon completing the webinar, you will have access to the CE quiz within the course you are taking. Find the CE quiz and click “purchase.” NAADAC members will be prompted to register for the CE quiz for free, while non-members will be prompted to pay a $25 processing fee to access the quiz.
  2. A score of 80% or higher is required to pass the CE quiz and access your CE certificate. You have 10 opportunities to pass the quiz. If you are unable to pass the quiz in the allocated number of tries, then you must retake the course.
  3. Upon passing the CE quiz, you will be required to complete the survey evaluation for the course. Once that is completed, your CE certificate will be immediately available to print. All certificates will be stored in the NAADAC Education Center under your profile name. Click here for instructions on how to access your CE certificates.

Click here for a complete list of organizations who approve NAADAC to provide continuing education hours.

This webinar is NOT eligible for ASWB ACE CE hours or NASW CE hours.

Who Should Attend
Addiction professionals, employee assistance professionals, social workers, mental health counselors, professional counselors, psychologists, and other helping professionals that are interested in learning about addiction-related matters.
Accessibility
Live closed captioning is available and the captioning capabilities are in compliance with the practices defined in Worldwide Web Consortium’s (W3C) Web Content Accessibility Guidelines (WCAG) and Section 508 of the Rehabilitation Act. In addition, transcripts are available for on-demand webinars recorded on and after March 27, 2019.

Questions, comments, or concerns about NAADAC Education? Take a look at our Webinar FAQs or email NAADAC.

Click here to learn about system requirements for NAADAC Webinars.

This presentation is for individual use only and may not be reproduced without permission from NAADAC.

Section 2